Respiratory Health Registry measuring lung function in different groups
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This registry study collects information and measures lung function to better understand respiratory health across people with cystic fibrosis, other lung diseases, and healthy volunteers. Your results may help researchers track lung health and improve future research and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in one of these groups: cystic fibrosis, another lung disease, or no lung disease
- If you have cystic fibrosis, you must have a CF diagnosis (including tests like newborn screen, sweat test, or CF gene results)
- A clinician must confirm you have a lung condition if you’re in the “other respiratory disease” group
- You (or your parent/guardian) must be able to give consent
- You must be well enough to do the lung function test on the day of testing
- You generally must not need extra oxygen to keep oxygen levels above 95%
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects health information (and some lab samples) from Chinese children who may have cystic fibrosis (CF). It helps researchers better understand CF in children and how it is diagnosed.
This study tests if people with cystic fibrosis can collect sputum samples at home and mail them in, instead of coming to the clinic. It aims to make participation easier for patients.
This study looks at how where your body stores fat may be linked to changes in metabolism and lung function over time in people with cystic fibrosis. It also compares results with healthy people similar in age, sex, and body size to understand the differences better.
This study collects cells from people with cystic fibrosis (CF) caused by rare CFTR gene changes. The goal is to build a cell bank for future research, which may help scientists develop better tests and treatments for rare CF types.
This trial tests a new device that measures how your sweat glands react to a common asthma medication. It aims to better classify people with cystic fibrosis or related diseases, and also includes healthy volunteers and carriers.
This study tests new treatments for cystic fibrosis in people who cannot take or choose not to take current CFTR modulators. It aims to find better options for managing CF.
Hear when a new Respiratory Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.